Clinical Trial Update: Comparison of SmartGuard vs Temp Target in Patients With Type 1 Diabetes Users of Advanced Hybrid Closed Loop System (AHCL) in Anaerobic Physical Activity. [NA]

View source ↗

Summary

A clinical trial updating a comparison of SmartGuard versus Temp Target within an advanced hybrid closed-loop insulin delivery system during anaerobic exercise …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Hospital Universitario San Ignacio | Conditions: Type 1 Diabetes (T1D), Exercise | NA | Status: NOT_YET_RECRUITING